肺腺癌肺结节实性体积比在肺腺癌中的预后价值
本研究回顾性分析2014年6月至2023年6月在本院胸外科行手术切除并经病理确诊的154例肺腺癌患者的临床、病理及CT资料,采用多因素COX分析寻找影响治疗效果的独立因素。结果显示,性别(P=0.009,OR:4.197,95%CI:1.426-12.353)和实性体积比(SVR)(P=0.004,OR:1.021,95%CI:1.007-1.036)是复发的独立预测因素;SVR(P=0.003,OR:1.028,95%CI:1.009-1.046)是术后生存的独立预测因素。作者认为,与实性成分肿瘤比率(CTR)相比,SVR在评估肺腺癌治疗效果方面具有一定价值。
要点
- SVR是肺腺癌术后复发(P=0.004,OR:1.021,95%CI:1.007-1.036)和生存(P=0.003,OR:1.028,95%CI:1.009-1.046)的独立预测因素。
- 性别为复发的独立预测因素(P=0.009,OR:4.197,95%CI:1.426-12.353)。
- 作者认为,与CTR相比,SVR在评估肺腺癌治疗效果方面具有一定价值。
核心结论
- SVR是肺癌术后复发和生存的独立预测因素,为术后疗效评估提供了新思路;与CTR相比,SVR在评估肺腺癌治疗效果方面具有一定价值。
研究设计与样本
- 本研究为回顾性分析,纳入2014年6月至2023年6月在本院胸外科行手术切除并经病理确诊的肺腺癌患者154例(男82例、女72例,平均年龄62.11±8.74岁),分析其临床、病理及CT资料,采用多因素COX分析寻找影响治疗效果的独立因素,P<0.05为差异有统计学意义。
诊断标准与关键数值
- 术后3年无病生存(DFS)率为87.5%,总生存(OS)率为92.0%;术后5年DFS率为81.6%,OS率为89.1%。
- 多因素COX回归显示,性别(P=0.009,OR:4.197,95%CI:1.426-12.353)和实性体积比(SVR)(P=0.004,OR:1.021,95%CI:1.007-1.036)是复发的独立预测因素。
- 多因素COX分析显示,SVR(P=0.003,OR:1.028,95%CI:1.009-1.046)是肺癌患者术后生存的独立预测因素。
临床应用与阅片要点
- 作者认为,与CTR相比,SVR在评估肺腺癌治疗效果方面具有一定价值。
- SVR是肺癌术后复发和生存的独立预测因素,为术后疗效评估提供了新思路。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVE: To evaluate solid volume ratio (SVR) in predicting long-term postoperative outcomes in lung adenocarcinoma patients.
METHODS: This study retrospectively analysed the clinical, pathological, and CT data of patients with lung adenocarcinoma who underwent surgical resection and were pathologically confirmed in the Department of Thoracic Surgery of our hospital from June 2014 to June 2023. Multivariate COX analysis was also conducted to identify independent factors that affect treatment effect. P < .05 was considered statistically significant.
RESULTS: A total of 154 patients (82 males and 72 females) were included in this study. The average age was 62.11 ± 8.74 years. There were 60 patients (38.96%) who smoked, and 63 patients (40.90%) had positive pleural invasion. The 3-year disease-free survival (DFS) rate and overall survival (OS) rate after surgical resection were 87.5% and 92.0%, respectively; the 5-year DFS rate and OS rate after surgical resection were 81.6% and 89.1%, respectively. Multiple COX regression analysis showed that gender (P = .009, odds ratio [OR]: 4.197, 95% confidence interval [CI]: 1.426-12.353), and the solid volume ratio (P = .004, OR: 1.021, 95% CI: 1.007-1.036) were identified as an independent predictor of recurrence. Multivariate COX analysis showed that SVR (P = .003, OR: 1.028, 95% CI: 1.009-1.046) was identified as an independent predictor of postoperative survival in patients with lung cancer.
CONCLUSION: In this study, compared with consolidation tumour rate (CTR), the SVR has certain value in evaluating the therapeutic efficacy of lung adenocarcinoma.
ADVANCES IN KNOWLEDGE: SVR is an independent predictor of postoperative recurrence and survival in lung cancer, and provides new ideas for postoperative efficacy evaluation.
引用
- Liu HX, Hu HX, Ji YQ, et al. The prognostic value of the solid volume ratio of pulmonary nodules in lung adenocarcinoma. Br J Radiol. 2026. PMID: 41400845. doi:10.1093/bjr/tqaf299
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。